Study to Determine the Optimal Starting Dose of FSH in a Low- Dose-Stepup Regime
Not Applicable
- Conditions
- WHO group II ovarian failure (first-grade amenorrhea, oligomenorrhea, or anovulatory cycle), luteal phase insufficiency, or unexplained infertility
- Registration Number
- JPRN-UMIN000015669
- Lead Sponsor
- Department of Obstetrics and Gynecology,Tokushima University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1)WHO group I ovarian failure (second-grade [central] amenorrhea) 2)WHO group III ovarian failure (ovarian amenorrhea) 3)Hyperprolactinemia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of subjects whose dominant follicles grow to a mean diameter of 18 mm within 10 days after starting FSH administration and the cumulative FSH dose needed to reach this endpoint
- Secondary Outcome Measures
Name Time Method